Percutaneous Injection of Polymethyl Methacrylate for the Treatment of Osteoarthritic Knee Pain Caused by Bone Marrow Edema: A Case Report and Review of LiteratureLi-Hua Gao*, Gui-Qiang Miao, Xue-Hui Zang, Hui Sun and Li-Hui Wang
Nanhai Hospital of Southern Medical University and People’s Hospital of Nanhai District of Foshan, Guangdong 528200, Hong Cong Sar, China
- *Corresponding Author:
- Gao LH
Nanhai Hospital of Southern Medical University and People’s Hospital of Nanhai District of Foshan
Hong Cong Sar, China
E-mail: [email protected]
Received Date: March 27, 2017; Accepted Date: June 07, 2017; Published Date: June 15, 2017
Citation: Gao LH, Miao GQ, Zang XH, Sun H, Wang LH (2017) Percutaneous Injection of Polymethyl Methacrylate for the Treatment of Osteoarthritic Knee Pain Caused by Bone Marrow Edema: A Case Report and Review of Literature. J Cytol Histol 8: 452. doi: 10.4172/2157-7099.1000452
Copyright: © 2017 Gao LH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Osteoarthritis is a common disease that affects the elderly peoples, with a detrimental effect on quality of life as a result of pain, and total joint replacement is usually the last option for end-stage osteoarthritis. However, for those whom have complex diseases, total joint replacement was limited. Thus, looking for an alternative way to relieve pain is necessary. Recently, bone marrow edema is has been demonstrated to associate with knee pain and osteoarthritis. Thus, targeting bone marrow edema may provide a promising approach for relieving knee pain and delayed osteoarthritis development and progression. The present study highlights the importance of bone marrow edema to recurrent knee pain, and demonstrates an alternative way for treating patients who have osteoarthritic knee pain caused by bone marrow edema, and are not suitable for total knee replacement as a result of contraindications such as multiple internal diseases and high risk of operation.